doi: 10.1016/j.micinf.2005.07.019.
Epub 2005 Sep 15.
Criteria for selection of HIV vaccine candidates--general principles
Affiliations
- PMID: 16213181
- DOI: 10.1016/j.micinf.2005.07.019
Item in Clipboard
Criteria for selection of HIV vaccine candidates--general principles
Microbes Infect.
2005 Nov.
Free article
Abstract
The generation of a vaccine against HIV/AIDS is extremely challenging, as evidenced by more than 20 years of attempts. Here are highlighted the strategies adopted within the AIDS Vaccine Integrated project (AVIP) to speed up the clinical evaluation of novel vaccine candidates and to increase the chances to get an effective preventive and/or therapeutic vaccine.
Similar articles
-
The rationale behind a vaccine based on multiple HIV antigens.Microbes Infect. 2005 Nov;7(14):1414-23. doi: 10.1016/j.micinf.2005.07.017. Epub 2005 Sep 29. Microbes Infect. 2005. PMID: 16257558
-
Vaccines based on Nef and on Nef/DeltaV2 Env.Microbes Infect. 2005 Nov;7(14):1400-4. doi: 10.1016/j.micinf.2005.07.015. Epub 2005 Sep 15. Microbes Infect. 2005. PMID: 16243564
-
Gene combination raises broad human immunodeficiency virus-specific cytotoxicity.Hum Gene Ther. 2001 Sep 1;12(13):1623-37. doi: 10.1089/10430340152528129. Hum Gene Ther. 2001. PMID: 11535166 Clinical Trial.
-
Candidate HIV-1 Tat vaccine development: from basic science to clinical trials.AIDS. 2006 Nov 28;20(18):2245-61. doi: 10.1097/QAD.0b013e3280112cd1. AIDS. 2006. PMID: 17117011 Review. No abstract available.
-
Cellular and molecular interactions in HIV infections: a review.East Afr Med J. 2002 May;79(5):249-53. East Afr Med J. 2002. PMID: 12638808 Review.
Cited by
-
Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes.Pharm Res. 2007 Oct;24(10):1870-82. doi: 10.1007/s11095-007-9310-8. Epub 2007 May 3. Pharm Res. 2007. PMID: 17476465
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
